Official title and information are available only for Plus and Premium subscribers.
Technology PROJECT ATLAS™ is an IP and know-how platform that turns scientific peptide capabilities into transferable commercial assets. The portfolio covers 11 technology platforms spanning peptide stability/formulation, advanced delivery, professional dermocosmetic engines, transmucosal delivery, bioprocess media, and adjacent enabling layers. Seeking industrial partners, CDMOs, beauty/pharma companies and intermediaries for asset sale, licensing or strategic transaction — under NDA for detailed diligence.
To see the additional information details please login and subscribe to a Plus or Premium account.
